Drugs / Ti02 pigmentary
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00483496 | Sep 2007 → Apr 2008 | solar urticaria | Orfagen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ti02 pigmentary | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00483496 ↗ |
| Route | Topical | “grid to be applied on the back skin; 1 product by grid window” NCT00483496 ↗ |